B. Riley lowered the firm’s price target on Axcelis to $200 from $240 and keeps a Buy rating on the shares post the Q3 report. The analyst believes the company’s growth can continue in 2024 “but at a more moderate level,” with an acceleration in 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACLS:
